Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Medexus Pharmaceuticals Inc (MEDXF)

Medexus Pharmaceuticals Inc (MEDXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Medexus Announces Strong Fiscal Q1 2025 Results Newsfile - Wed Aug 7, 4:44PM CDT

Fiscal Q1 2025 revenue of $27.3 million, net income of $2.0 million, operating income of $4.0 million, and Adjusted EBITDA* of $6.1 millionManagement to host conference call at 8:00 AM Eastern time on...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
Medexus Schedules First Fiscal Quarter 2025 Conference Call Newsfile - Tue Jul 30, 4:38PM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - July 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, August...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
Medexus Generates Record Revenue of US$113.1 Million in Fiscal Year 2024 Newsfile - Tue Jun 25, 4:38PM CDT

FDA has Accepted for Review the Treosulfan NDAManagement to host conference call at 8:00 AM Eastern time on Wednesday, June 26, 2024Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2024)...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call Newsfile - Tue Jun 18, 4:06PM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Wednesday, June 26,...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
FDA Accepts for Review Treosulfan NDA Resubmission Newsfile - Thu Jun 6, 9:24AM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 6, 2024) - On Thursday, June 6, 2024, Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) was informed by medac, licensor of Medexus's commercialization...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada Newsfile - Wed May 1, 4:44PM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - May 1, 2024) - Following a trial in January 2023, Canada's Federal Court has issued a judgment declining to uphold the Canadian patent for Metoject®....

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference Newsfile - Tue Apr 2, 6:32AM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
FDA Approves Medexus's Supplemental Biologics License Application for IXINITY(R) to Treat Hemophilia B in Pediatric Patients Newsfile - Tue Mar 26, 7:04AM CDT

Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age groupToronto, Ontario and Chicago, Illinois--(Newsfile...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
Medexus Announces Fiscal Q3 2024 Results Newsfile - Wed Feb 7, 5:08PM CST

Fiscal Q3 2024 revenue of $25.2 million, Operating income of $1.6 million, and Adjusted EBITDA* of $3.2 millionManagement to host conference call at 8:00 AM Eastern time on Thursday, February 8, 2024Toronto,...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)
Medexus Schedules Third Fiscal Quarter 2024 Conference Call Newsfile - Tue Jan 30, 6:04AM CST

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February...

MEDXF : 2.0000 (+0.45%)
MDP.TO : 2.73 (+0.37%)

Barchart Exclusives

Is Oracle Stock a Buy or Sell After Earnings? Barchart - 1 hour ago
After this software stock rallied double-digits on its Q1 earnings release, should investors consider buying the stock or cash out? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot